Literature DB >> 7008289

Effect of a single transfusion of donor-specific and nonspecific blood on skin allograft survival in mice.

H Okazaki, T Maki, M Wood, A P Monaco.   

Abstract

The effect of a single transfusion of donor-specific or nonspecific blood on skin allograft survival was studied in ALS-treated mice. In the weak H-2-incompatible C3H/He to B6AF1 combination, transfusion of outbred CF1 blood induced significant prolongation of C3H/He skin graft survival when given over a wide interval of days between transfusion and skin grafting. In contrast, donor-specific C3H/He blood was effective only when given 10 days before grafting. Transfusion of either red blood cells or lymphocytes separated from CF1 or C3H/He whole blood also prolonged C3H/He skin graft survival. In the relatively strong H-2 incompatible DBA/2 to B6AF1 combination, significant prolongation of DBA/2 skin grafts was induced only by transfusion of donor-specific DBA/2- and H-2-compatible BALB/c blood. A single transfusion of C3H/He or CF1 blood failed to prolong DBA/2 skin graft survival. In the strong H-2-incompatible DBA/1 to B6AF1 combination, donor-specific DBA/1 blood was effective in prolonging DBA/1 skin graft survival. These results demonstrate that the effectiveness of donor-specific or nonspecific blood is dependent on (1) the degree of H-2 incompatibility of donor-recipient pairs and (2) timing of the blood transfusion relative to skin grafting.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7008289     DOI: 10.1097/00007890-198012000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.

Authors:  S Kitagawa; S Sato; S Hori; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

2.  Direct evidence for clonal destruction of allo-reactive T cells in the mice treated with cyclophosphamide after allo-priming.

Authors:  T Maeda; M Eto; Y Nishimura; K Nomoto; Y Y Kong; K Nomoto
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

3.  Cell-cell interaction in graft rejection responses: induction of anti-allo-class I H-2 tolerance is prevented by immune responses against allo-class II H-2 antigens coexpressed on tolerogen.

Authors:  S Hori; S Kitagawa; H Iwata; T Ochiai; K Isono; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

4.  Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.

Authors:  S Kitagawa; H Iwata; S Sato; J Shimizu; T Hamaoka; H Fujiwara
Journal:  J Exp Med       Date:  1991-09-01       Impact factor: 14.307

Review 5.  Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls.

Authors:  Brian I Shaw; Jeffrey R Ord; Chloe Nobuhara; Xunrong Luo
Journal:  Front Immunol       Date:  2021-08-30       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.